PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.41%
Revenue growth similar to 3391.T's 8.17%. Walter Schloss would see if both companies share industry tailwinds.
9.37%
Gross profit growth similar to 3391.T's 9.45%. Walter Schloss would assume both firms track common industry trends.
0.78%
Positive EBIT growth while 3391.T is negative. John Neff might see a substantial edge in operational management.
22.36%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
5.48%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
5.48%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
5.48%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
23.00%
10Y revenue/share CAGR under 50% of 3391.T's 129.44%. Michael Burry would suspect a lasting competitive disadvantage.
-5.88%
Negative 5Y CAGR while 3391.T stands at 104.39%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-32.18%
Negative 3Y CAGR while 3391.T stands at 75.97%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
38.40%
Below 50% of 3391.T's 230.48%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-5.96%
Negative 5Y net income/share CAGR while 3391.T is 210.45%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-29.07%
Negative 3Y CAGR while 3391.T is 23.14%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
90.52%
10Y equity/share CAGR at 50-75% of 3391.T's 124.45%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
28.29%
Below 50% of 3391.T's 90.85%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-15.26%
Negative 3Y equity/share growth while 3391.T is at 45.71%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-41.67%
Cut dividends over 10 years while 3391.T stands at 68341.93%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-50.00%
Negative 5Y dividend/share CAGR while 3391.T stands at 303314.49%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
16.67%
Below 50% of 3391.T's 60.00%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
16779.31%
AR growth well above 3391.T's 25.85%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.78%
Inventory growth well above 3391.T's 0.78%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
7.63%
Asset growth well under 50% of 3391.T's 17.12%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.31%
Similar to 3391.T's 4.16%. Walter Schloss finds parallel capital usage or profit distribution strategies.
12.23%
We have some new debt while 3391.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-45.53%
We cut SG&A while 3391.T invests at 16.75%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.